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Abstract: Advanced glycation end-products (AGEs) are involved in the pathogenesis and
consequences of polycystic ovary syndrome (PCOS), a complex metabolic disorder associated
with female infertility. The most powerful AGE precursor is methylglyoxal (MG), a byproduct of
glycolysis, that is detoxified by the glyoxalase system. By using a PCOS mouse model induced
by administration of dehydroepiandrosterone (DHEA), we investigated whether MG-dependent
glycative stress contributes to ovarian PCOS phenotype and explored changes in the Sirtuin 1
(SIRT1) functional network regulating mitochondrial functions and cell survival. In addition to
anovulation and reduced oocyte quality, DHEA ovaries revealed altered collagen deposition, increased
vascularization, lipid droplets accumulation and altered steroidogenesis. Here we observed increased
intraovarian MG-AGE levels in association with enhanced expression of receptor for AGEs (RAGEs)
and deregulation of the glyoxalase system, hallmarks of glycative stress. Moreover, DHEA mice
exhibited enhanced ovarian expression of SIRT1 along with increased protein levels of SIRT3 and
superoxide dismutase 2 (SOD2), and decreased peroxisome proliferator-activated receptor gamma
co-activator 1 alpha (PGC1α), mitochondrial transcriptional factor A (mtTFA) and translocase of
outer mitochondrial membrane 20 (TOMM20). Finally, the presence of autophagy protein markers
and increased AMP-activated protein kinase (AMPK) suggested the involvement of SIRT1/AMPK
axis in autophagy activation. Overall, present findings demonstrate that MG-dependent glycative
stress is involved in ovarian dysfunctions associated to PCOS and support the hypothesis of a
SIRT1-dependent adaptive response.
Keywords: PCOS; advanced glycation end-products; methylglyoxal; glycative stress; glyoxalases;
SIRT1; SIRT3; oocyte quality; mitochondria; oxidative stress
1. Introduction
Polycystic ovarian syndrome (PCOS) is a common and complex endocrine disorder affecting
4–21% of women in reproductive age [1,2]. According to the Rotterdam criteria, the PCOS classic
phenotype consists of hyperandrogenism, oligo-ovulation and polycystic ovaries, in association with
insulin resistance, metabolic disorders and infertility [3]. Long-term risks conferred by PCOS include
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diabetes and cardiovascular disease. Although underlying mechanisms have not been fully elucidated
yet, a crucial role in the pathogenesis of PCOS is played by oxidative stress [4,5].
In the last decade, new players have been implicated in the pathogenesis of PCOS, the advanced
glycation end products (AGEs). Glycation is a spontaneous non-enzymatic reaction of reducing sugars
with free amino groups of proteins, DNA and lipids that forms Amadori products. The Amadori
products undergo a variety of irreversible dehydration and rearrangement reactions that ultimately lead
to the formation of AGEs [6]. Physiological glycation involves the modification of proteins by reactive
α-oxoaldehydes—particularly glyoxal, methylglyoxal and 3-deoxyglucosone. The most powerful
precursor of AGEs is methylglyoxal (MG), a low-molecular weight dicarbonyl compound derived
from metabolic processes [7]. MG reacts primarily with arginine residues to form hydroimidazolones
and argpyrimidine [8,9], here referred to as MG-AGEs. Intracellular MG detoxification relies on the
activity of the so-called glyoxalase system, composed of glyoxalase 1 (GLO1) and glyoxalase 2 (GLO2).
GLO1 converts MG to S-d-lactoylglutathione in a glutathione (GSH)-dependent manner, whereas
GLO2 catalyses the hydrolysis of S-d-lactoylglutathione to d-lactate, thus regenerating GSH [10]. MG
build-up may derive from increased glycolytic metabolism and/or reduced glyoxalase activity, which
may occur as a result of reduced GSH availability (e.g., oxidative stress) and/or decreased glyoxalase
expression (e.g., aging) [10]. The accumulation of MG affects mitochondrial proteins and increases
AGEs, which can also activate receptor-mediated pro-oxidant signalling pathways, thus generating a
vicious cycle. Therefore, oxidative stress is considered an important aspect of the glycative burden,
here referred to as glycative stress [10].
Increased levels of AGEs have been detected in the serum and ovary of women affected by
PCOS [11–13]. Moreover, serum AGEs correlate positively with altered glucose metabolism, age and
factors related to obesity, dyslipidaemia, hyperglycaemia and insulin resistance in patients undergoing
in vitro fertilization (IVF) [14]. Further evidence for the role of AGEs in PCOS was provided by
measurements in granulosa cells and serum of soluble receptors for AGEs (s-RAGE), a circulating
isoform of RAGE that can neutralize the ligand-mediated damage [15]. A potential role of MG in
PCOS was supported by the finding that dietary glycotoxins and hyperandrogenic status decrease
GLO1 activity in rat ovaries, possibly contributing to increased AGE accumulation in granulosa
cells [16]. We have recently shown in mice that dietary MG increased serum level of androstenedione,
which may suggest a role of MG and AGEs in the hyperandrogenic status associated with PCOS.
Moreover, we observed in the same model that the response to MG-dependent glycative stress in
the female gonad involved a Sirtuin 1 (SIRT1) functional network [17]. SIRT1, a NAD+-dependent
enzyme with deac(et)ylase activity, is the most studied member of the sirtuin family playing a key role
during folliculogenesis by regulating mitochondrial biogenesis, oxidative stress defense and energy
homoeostasis [18,19].
In the present work, we hypothesized that MG-dependent glycative stress participates in ovarian
PCOS phenotype and explored whether this condition is associated with deregulation of SIRT1
functional network regulating mitochondrial physiology and cell survival. To this end, we relied
on a dehydroepiandrosterone (DHEA)-induced PCOS model developed in CD1 mice [20], known
to share many of the salient features with human PCOS patients [21]. The occurrence of PCOS
was confirmed by analysing different parameters including follicle population, ovarian fibrosis,
dyslipidemia, oestrous cycle, ovulation, oocyte quality and oxidative stress. Glycative stress was
assessed by evaluating ovarian accumulation of MG-AGEs, expression of RAGEs and glyoxalases. In
particular, we focused on argpyrimidine, an MG-AGE, which has known to be correlated with mouse
and human ovarian dysfunctions [22–24]. Among the proteins that mediate the SIRT1-dependent action
on mitochondria, a key role is played by peroxisome proliferator-activated receptor gamma co-activator
1 alpha (PGC1α) [25], the superoxide dismutase 2 (SOD2) and SIRT3, along with mitochondrial
proteins such as mitochondrial transcriptional factor A (mtTFA), which is a downstream effector of
SIRT1/PGC1α and indirect marker of mitochondrial number [25,26]. Under stress conditions, SIRT1
cooperates with AMP-activated protein kinase (AMPK) in order to restore energy balance or promoting
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cell death [27]. Thus, we explored whether in PCOS mouse ovaries activation of a SIRT1/AMPK axis
may be associated with increased autophagy, a type of cell death recently found in PCOS ovarian
cells [28,29].
Here we demonstrated that MG-dependent glycative stress is involved in ovarian dysfunctions
associated to PCOS and suggest that this condition contributes to deregulation of SIRT1 functional
network, mitochondrial mass and redox milieau and autophagy.
2. Materials and Methods
2.1. Animals
Outbred CD-1 mice (Charles River Italia s.r.l., Calco, Italy) were maintained in a
temperature-controlled environment under a 12 h light/dark cycle (07:00–19:00) and free access
to feed and water ad libitum. All the experiments were carried out in in conformity with national
and international laws and policies (European Economic Community Council Directive 86/609, OJ
358, 1 Dec 12, 1987; Italian Legislative Decree 116/92, Gazzetta Ufficiale della Repubblica Italiana n.
40, Feb 18, 1992; National Institutes of Health Guide for the Care and Use of Laboratory Animals,
NIH publication no. 85-23, 1985). The project was approved by the Italian Ministry of Health and the
internal Committee of the University of L’Aquila.
Twenty 4 week-old, body weight 20–21 g, young CD-1 female mice were randomly assigned
to two groups (10 for each): mice daily injected (sub cutaneously) with DHEA (6 mg/100 g body
weight, 100 µL/mouse in sesame oil with 10% of 95% ethanol, Sigma-Aldrich, St. Louis, CO, USA) for
20 consecutive days (DHEA mice) [20,21]. The vehicle control group was injected with 0.09 mL sesame
oil and 0.01 mL 95% ethanol daily for 20 consecutive days (control mice). Mice were sacrificed by an
inhalant overdose of carbon dioxide (CO2, 10–30%), followed by cervical dislocation. All efforts were
made to minimize suffering.
2.2. Estrous Cycle Determination
Analysis of vaginal smears was performed daily from the 7th day after the first injection of
DHEA or vehicle. The stages of the estrous cycle were determined daily based on direct examination
(“wet smear”) technique [30]. Vaginal cells were collected via saline lavage and then observed under
light microscope with a 10× objective. Predominant nucleated epithelial cells and some cornified
epithelial cells indicated the proestrous stage; predominant cornified squamous epithelial cells indicated
the estrous stage; both cornified squamous epithelial cells and leukocytes indicated the metaestrous
stage; and predominant leukocytes indicated the diestrous stage.
2.3. Superovulation Induction and Oocyte Collection
In order to obtain mature oocytes, at 48 h after the last treatment, the remaining three mice per
group were treated for the induction of super ovulation by intraperitoneal injection of 10 IU pregnant
mare’s serum gonadotropin (PMSG) (Folligon; Intervet-International, Boxmeer, Holland), followed by
10 IU human chorionic gonadotropin (hCG) (Profasi HP 2000; Serono, Roma, Italy) 48 h apart. Fifteen
hours after hCG, oviducts were removed and oocytes arrested at metaphase II (MII) stage were isolated
after a brief exposure to 0.3 mg/mL hyaluronidase (Sigma-Aldrich).
2.4. H&E Staining and Ovarian Follicle Classification and Counting
Part of the ovaries was sliced in half. One half of each ovaries was fixed in 3.7% paraformaldehyde
(PFA) in PBS (Bio-Optica, Milan, Italy) for 12–16h Haematoxylin and Eosin (H&E) staining, dehydrated
in the ascending series of alcohol, clarified in xylene and embedded in paraffin blocks. Samples
were cut with a microtome (Leica SMR2000, Wetzlar, Germany) and sliced into 6 µm serial sections.
Sections were then deparaffined and hydrated through xylenes and descending series of alcohol,
stained with H&E according to the manufacturer’s instruction (Bio Optica, Milan, Italy) and observed
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by light microscopy (Zeiss Axiostar Plus, Oberkochen, Germany). Follicle classification and counting
was performed by counting at least three serial sections/slide (20 slices in average for ovary), spaced
~50 µm each.
Stained ovarian follicles were classified as normal or degenerated for the qualitative evaluation.
The normal follicles were those that presented the complete basal membrane, absence of pyknotic
bodies in the oocyte nucleus, without signs of oocyte and/or granular degeneration. Normal follicles
were classified according Gougeon’s classification [31] in: (i) primordial follicle, oocyte surrounded by
a single layer of flattened pre-granulosa cells; (ii) primary follicle, oocyte showing a single layer of
cuboidal granulosa cells; (iii) secondary follicle, with at least two complete layers of granulosa cells;
and (iv) antral follicle, with development of an antral cavity.
2.5. Heidenhain’s AZAN Trichrome Staining
Paraffin embedded sections of formalin-fixed ovarian tissue were deparaffinized and hydrated
through xylenes and graded alcohol series and processed for trichrome staining (Electron Microscopy
Sciences, Danvers, MA, USA), according to manufacturer’s instructions.
2.6. Ovarian Immunofluorescence Analysis
Some half of the ovaries were fixed in 3.7% PFA/PBS (Bio Optica, Milan, Italy) for
immunofluorescence analysis or sunk in liquid nitrogen and stored at −80 ◦C until processing.
The following immunofluorescence markers were used: 17 beta-hydroxysteroid dehydrogenase type 4
(17β-HSD4), translocase of outer mitochondrial membrane 20 (TOMM20), Von Willebrand Factor (vWF)
and alpha smooth muscle actin (α-SMA). After fixation, samples were washed in PBS for 10 min at room
temperature (RT) and then incubated with 3% BSA/PBS (Sigma-Aldrich) for 1 h at RT or avidin/biotin
blocking followed by M.O.M mouse IgG blocking reagent (Vector Laboratories, Burlingame, CA, USA,
when mouse antibodies were used), according to the manufacturer’s instructions. After washing with
PBS, ovarian sections were incubated with the following primary antibodies: rabbit polyclonal to
17β-HSD4, TOMM20 (1:100 and 1:400 respectively) (ThermoFisher Scientific, Rockford, IL, USA), vWF
(1:500) (Dako, Glostrup, Denmark), all diluted in 3% BSA/PBS, for 1 h at RT and mouse monoclonal
to α-SMA, (1:500) (Abcam, Cambridge, UK), diluted in M.O.M (Mouse on Mouse) diluent for 30
min, according to the manufacturer’s instructions. After washing with PBS, rabbit antibodies were
revealed by donkey anti rabbit IgG Alexa Fluor 633 conjugated secondary antibody (1:2000) (Molecular
Probes, Thermofisher), whereas mouse antibodies were recognized by biotinylated anti-mouse IgG
(1:300, Vector), revealed by Fluorescein Avidin DCS (1:100), according to the manufacturer’s instructions.
For the BODIPY staining, ovarian sections were incubated with 4,4-difluoro-1,3,5,7,8-pentamethyl
4-bora-3a,4a-diaza-sindacene (1 µg/mL, BODIPY 493/503 Molecular Probes, Invitrogen, Carlsbad, CA,
USA), for 10 min, at RT. Finally, sections were mounted with Vectashield Mounting Medium with
4′,6-diamidino-2-phenylindole (DAPI) (Vector Laboratories, Burlingame, CA, USA) and examined
under a Leica TCS SP5 confocal microscope (Mannheim, Germany).
Negative controls were performed by omitting the primary antibodies and substituting them with
PBS solution containing 3% BSA or M.O.M diluent alone.
The evaluation and automated scoring of immunofluorescence (IF) signals was performed by
using Image J 1.44p software according to Jensen [32].
2.7. Ovarian Immunohistochemical Analysis
Paraffin embedded sections of formalin-fixed ovarian tissue were deparaffinized and hydrated
through xylenes and graded alcohol series. To increase the immunoreactivity, the sections were boiled
in 10 mM citrate buffer (pH, 6.1 Bio-Optica, Milan, Italy) in a microwave at 720 W (3 cycles/3 min each).
The sections were then subjected to treatment for blocking endogenous peroxidase activity (Dako).
After thorough washing, sections were incubated with M.O.M mouse IgG blocking reagent overnight at
4 ◦C (Vector Laboratories) according to the manufacturer’s protocol. Then sections were incubated with
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mouse monoclonal to methylglyoxal (MG)-AGE (Arg-Pyrimidine, AGE06B, BioLogo, 1:100) antibody
or rabbit polyclonal to 4-HNE (4 Hydroxynonenal, ab46545, Abcam, 1:100) diluted in M.O.M diluent
for 30 min, according to the Vector Laboratories instructions. MG-AGE and 4-HNE were revealed
by biotinylated anti-mouse and anti-rabbit IgG, respectively, followed by streptavidin- horseradish
peroxidase (HRP), 3,3-diaminobenzidine (DAB) substrate buffer and DAB (Dako kit), according to
manufacturer’s instructions. Counterstaining was performed with hematoxylin (Bio-Optica). Negative
controls were performed by omitting primary antibody and substituting it with M.O.M diluent alone.
Finally, sections were dehydrated and mounted with Neomount (Merck, Darmstadt, Germany). They
were observed and photographed under a Leitz Laborlux S microscope (Germany) equipped with an
Olympus digital compact camera. The evaluation and automated scoring of immunohistochemistry
(IHC) signals was performed by using Image J 1.44p software (IHC profiler plugin) according to
Varghese et al. [33].
2.8. Western Blot Analysis
Part of the ovaries stored at −80 ◦C were processed for protein extraction. Ovarian tissues were
homogenized in RIPA buffer by repeated freeze/thaw cycles in liquid nitrogen. After centrifugation
(14,000 rpm for 90 min at 4 ◦C), the supernatants were collected for protein analysis. Protein
concentration was determined by BCA protein assay kit (Pierce, Rockford, IL, USA). Protein
samples were separated by SDS-PAGE and transferred to a polyvinylidene difluoride membrane
(Sigma-Aldrich). Non-specific binding sites were blocked for 1 h at room temperature with 5% not
fat dry milk (Bio-Rad Laboratories, Segrate, Italy) in Tris-buffered saline containing 0.05% Tween 20
(TBS-T). Membranes were incubated with polyclonal rabbit anti-SIRT1 antibody (Ab12193, Abcam;
1:700), anti-SIRT3 (Ab86671, Abcam, Cambridge, UK; 1:500), anti-SOD2 antibody (Ab86087, Abcam;
1:1000), anti-GLO1 antibody (MA1-13029, Thermo Fisher; 1:400), anti-GLO2 antibody (Ab154108,
Abcam; 1:500), anti-PGC1α antibody (SC-13067, Santa Cruz Biotechnology Inc., 1:500), anti-RAGE
(PA1-075, ThermoFisher Scientific, 1:750), mouse anti-Methylglyoxal (MG)-AGE (argpyrimidine)
monoclonal antibody (AGE06B, BioLogo; 1:250), anti-mtTFA antibody (SC-166965, Santa Cruz,
1:250), anti-17β-HSD4 antibody (PA5-21522, ThermoFisher Scientific, 1:250); anti-AMPKα1 antibody
(AB-84049, Immunological Sciences, Rome, Italy, 1:500), anti-phospho-AMPKα1 antibody (S487,
ABP-0619, Immunological Sciences, 1:500), anti-microtubule-associated protein light chain 3 (LC3)
antibody (AB-83557, Immunological Sciences, 1:500), anti-p62 (also known as sequestosome-1) antibody
(AB-83779, Immunological Sciences, 1:500) or anti-glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (TA802519, OriGene Technologies Inc, 1:750) overnight at 4 ◦C, followed by incubation
with horseradish peroxidase (HRP) conjugated anti-rabbit (BA1054, Boster Biological Technology Co.,
Ltd., 1:3000) or anti-mouse secondary antibody (Ab6728, Abcam, 1:2000) for 1 h at room temperature.
After washing, specific immunoreactive complexes were detected by ECL kit (Thermo Scientific,
Waltham, MA, USA) and Uvitec Cambridge system (Alliance series, Cambridge, UK). The bands were
normalized for GAPDH using ImageJ 1.44p software and values were given as relative units (RU). All
the experiments were performed in triplicate.
2.9. Analysis of DNA Distribution and Spindle Configuration of In Vivo Matured MII Oocytes
In vivo matured MII oocytes were fixed for immunofluorescence and labelled by mouse
anti-α-tubulin (T9026, Sigma Aldrich, 1:200) primary antibody overnight at 4 ◦C and secondary
goat anti mouse- antibody conjugated with Alexa 594 (A90-137D4, Bethyl Laboratories Inc., 1:500) for
1 h at room temperature. Chromatin staining was performed by 5 µg/mL Hoechst 33342 (Sigma-Aldrich)
for 5 min at room temperature. In negative control oocytes, the primary antibody was omitted. Oocytes
were mounted on slides and analysed under epifluorescence microscope at 100×magnification.
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2.10. Statistical Analysis
All data are presented as mean ± SEM. Statistical analysis was assessed by t-test. Analyses were
performed using the SigmaStat software (Jandel Scientific Corporation, San Rafael, CA, USA). A
p-value < 0.05 was considered statistically significant.
3. Results
3.1. Analysis of PCOS Phenotype in DHEA Mice
Most mice of control group (80%) showed normal estrous cyclicity, while all the mice of DHEA
group displayed abnormal estrous cycle. Representative cyclicities of mice in the two groups are
showed in Figure 1a. No differences were observed in the weight of mice of the two groups as shown
in Figure 1b.
1 
 
 
 
Figure 1 
 
 
 
Figure 1. Estrous cycle, body weight, ovarian morphology in the mice. (a) Representative estrous cycle
of one mouse from control and dehydroepiandrosterone (DHEA) group. (b) Body weight. Ten mice
per experimental group were employed. (c,d) representative Haematoxylin and Eosin (H&E) staining
of ovarian sections of CTRL (c) and DHEA (d) mice. (e) Atretic follicle. Three mice per experimental
group were employed. Experiments were done in triplicate. **, p < 0.001, t-test.
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Histologic examination of DHEA ovaries showed a looser appearance of the medullary and
cortical stroma, respect to control ovaries (Figure 1c,d). While the latter showed the general histological
organization of the mouse ovary—with an outer compact cortex rich of developing ovarian follicles,
corpora lutea and atretic follicles interspersed in stromal elements and interstitial gland cells—the
former were characterized by a loose aspect. More in detail, from a wide medullar stroma, rich of
blood vessels embedded in a loose collagenous matrix, numerous sepiments protruded in the cortex to
partially detach ovarian follicles and corpora lutea. The population of primordial, primary, secondary
and antral follicles seemed normal in density and morphology. However, evident corpora lutea were
seen, occasionally infiltrated by blood cells. Cystic-like structures with luteinized theca cells were
occasionally found. Numerous atretic follicles, from all developmental stages but more from antral
follicles, were also observed. Analysis of the follicle population in DHEA mice revealed that DHEA
administration induced a highly significant in atretic follicles (Figure 1e) with respect to controls.
As shown in Figure 2a,b, the microscopic evaluation of DHEA ovaries subjected to trichrome stain
evidenced a fibrotic aspect of ovarian cortex. In particular, the follicular wall of secondary and antral
follicles showed a concentric and network-like collagen distribution, more intense than in controls. A
thick and intense staining of collagen was detected also in medium-sized corpora lutea. As seen by
H&E staining, blood cells infiltration was diffusely present in corpora lutea of DHEA ovaries.
The simultaneous staining for vWF, an endothelial cell marker (green stain) and α-SMA, a perycite
marker (red stain) was used to identify the ovarian blood vessels. In both control and DHEA ovaries,
vWF did not co-localize α-SMA (Figure 2c–f). The endothelial network was localized in the thecal
layers of the ovarian follicles, and particularly in the antral follicles in both groups. In DHEA ovaries,
endothelial cells were diffusely found located into corpora lutea, strictly associated to luteal cell as in
atretic follicles. Groups of pericytes were spotted in the follicular and luteal walls. A diffuse staining
was observed in the ovarian stroma, especially in DHEA ovaries. Overall, both vWF and α-SMA were
more expressed in DHEA ovaries.
BODIPY staining after DHEA administration was stronger than in controls (Figure 2i,l). While in
controls lipid droplets were visible as punctiform spots in the stroma, follicles and corpora lutea, DHEA
ovaries showed the more abundant presence of larger lipid droplets. The anti 17β-HSD4 antibody
immunostained strongly DHEA ovaries, with respect to controls (Figure 2g,h). The latter presented a
diffuse and light staining in the ovarian stroma, more evident in the thecal layers of antral follicles and
into the corpora lutea. DHEA ovaries showed an intense staining in the ovarian surface epithelium.
Finally, we confirmed the establishment of a condition of oxidative stress in DHEA mouse ovaries
by evaluating lipid peroxidation [34]. As shown in Supplementary Figure S1, DHEA administration
induced a significant increase in 4-HNE immunostaining.
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Figure 2. Representative images of trichrome staining in CTRL (a) and DHEA (b) mice.
(c–f) Immunolocalization of Von Willebrand Factor (vWF) (green) and alpha smooth muscle
actin (α-SMA) (red) in control (c,c’ and e,e’) and DHEA (d,d’ and f,f’) ovarian sections.
(g–h) Immunolocalization of 17 beta-hydroxysteroid dehydrogenase type 4 (17β-HSD4) (red) in
control (g) and DHEA (h) ovarian sections. Staining of lipid droplets by BODIPY 493/503 (green)
in control (i) and DHEA (l) ovarian section. (c–l) DNA is stained by DAPI (blue). Three mice per
experimental group were employed. Experiments were done in triplicate.
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3.2. DHEA Induced Ovulatory Dysfunction during Superovulation and Negatively Influences Oocyte Quality
As reported in Table 1, DHEA administration negatively affected the mean number of ovulated
oocytes per mouse after ovarian stimulation with gonadotropins (Table 1). Since normal metaphase
configuration is crucial to oocyte quality, we analysed the effect of DHEA administration on spindle
and chromosome organization in MII oocytes obtained following superovulation. The MII plate was
classified as ‘normal’ when microtubules formed two opposite poles in association with a normal
chromosomal distribution or ‘aberrant’ if microtubule structures displayed reduced dimensions of the
spindle or lost normal poles or if disorganized microtubule patterns were observed in association with
scattered, decondensed or disorganized chromosomes [35] (Figure 3). According to this classification,
our data showed that percentage of oocytes with normal MII plate decreased about 40% in oocytes of
DHEA group compared to control (Table 1).
Table 1. Effect of DHEA on ovulatory function and oocyte quality.
CTRL (Mean ± SEM) DHEA (Mean ± SEM)
No. of oocytes from per mouse 17.4 ± 1.0 10.8 ± 1.0 **
Percentage of MII oocytes 92.1 ± 1.2% 86.4 ± 3.9%
Percentage of MII oocytes with normal metaphase plate 77.2 ± 4.0% 44.0 ± 7.5% **
Percentage of degenerated oocytes 8.0 ± 1.2% 13.6 ± 3.9%
**, p < 0.01, t-test.
Figure 3. Representative images of MII plate observed in oocytes from control (a–a”) and DHEA (b–b”)
mice following induction of ovulation. Spindle is stained by α-tubulin (red) and chromosomes are
stained by Hoechst 33342 (blue). Five mice per experimental group were employed. Experiments were
done in triplicate.
3.3. Glycative Stress is Observed in the Ovary of DHEA Mice
The immunohistochemical analysis revealed an increased staining of MG-AGE in the ovaries of
DHEA mice. Results obtained in control ovaries revealed low immunoreactivity in granulosa cells from
primary, preantral and antral follicles, as well as in cumulus cells, oocytes and vessels. Nevertheless,
low levels of MG-AGE staining could be observed in stromal cells. By contrast, sections of DHEA
ovaries revealed an intermediate MG-AGE staining in oocytes and an intensive immunoreactivity in
luteal cells, vessels and stromal cells (Figure 4a–d). This observation was confirmed by the comparison
of the immunoreactive bands in DHEA and control groups (Figure 4e). MG-AGE accumulation was
further supported by enhanced protein expression of RAGEs in the ovaries of DHEA mice (Figure 4f).
To investigate the efficiency of the MG detoxification system, we assessed protein expression of GLO1
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and GLO2. GLO1 protein expression was significantly reduced in ovaries from DHEA mice when
compared with controls, whereas protein levels of GLO2 were increased (Figure 5).
 
2 
 
Figure 4 
Figure 4. Representative images of immunolocalization of methylglyoxal (MG)-advanced glycation
end-product (AGE) in control (a,b) and DHEA (c,d) ovaries. Western blot analysis of MG-AGE
(e) and receptor for AGE (RAGE) (g) and representative images (f). Data are presented as
means ± SEM of densitometric analysis of immunoreactive bands normalized to internal reference
protein (glyceraldehyde-3-phosphate dehydrogenase, GAPDH). Three mice per experimental group
were employed. Experiments were done in triplicate.*, p < 0.05; ***, p < 0.001, t-test.
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Figure 5. Western blot analysis of glyoxalase 1 (GLO1) (a) and GLO2 (b) and representative images
of immunoreactive bands (c). Data are presented as means ± SEM of densitometric analysis
of immunoreactive bands normalized to internal reference protein (glyceraldehyde-3-phosphate
dehydrogenase, GAPDH). Three mice per experimental group were employed. Experiments were done
in triplicate. ***, p < 0.001, t-test.
3.4. SIRT1 Functional Network Regulating Mitochondrial Physiology Is Disrupted in DHEA Ovaries
To investigate whether PCOS induced by DHEA administration is associated with deregulation
of SIRT1 functional network regulating mitochondrial physiology, we compared the levels of SIRT1
and proteins of SIRT1 mitochondrial network in control and DHEA mice. Data reported in Figure 6
revealed a significant increase of SIRT1 in DHEA mice. Moreover, we detected an upregulation of
mitochondrial proteins SIRT3 and SOD2. Nevertheless, we observed a lower amount of PGC1α, the
main regulator of mitochondrial biogenesis and function, and mtTFA, which reflects the rate of mtDNA
transcription and mtDNA content. Confocal analysis of TOMM20 ovarian staining showed a reduced
expression of the mitochondrial transporter in DHEA ovaries (Figure 7).
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Figure 6 Figure 6. Western blot analysis of Sirtuin 1 (SIRT1) (a), SIRT3 (b), peroxisome proliferator-activated
receptor gamma co-activator 1 alpha (PGC1α) (c), mitochondrial transcriptional factor A (mtTFA)
(d) and superoxide dismutase 2 (SOD2) (e) and representative images of immunoreactive bands (f).
Data are presented as means ± SEM of densitometric analysis of immunoreactive bands normalized
to internal reference protein (glyceraldehyde-3-phosphate dehydrogenase, GAPDH). Three mice per
experimental group were employed. Experiments were done in triplicate. *, p < 0.05, **, p < 0.01,
***, p < 0.001, t-test.
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Figure 7 Figure 7. Immunolocalization and quantification of translocase of outer mitochondrial membrane 20
(TOMM20) positive staining (red). DNA is stained by DAPI (blue). Representative images of TOMM20
in CTRL (a,a’) and DHEA (b,b’) mice. Quantification of TOMM20 positive staining in the experimental
groups (c). Data are presented as means ± SEM of mean pixel intensity of red fluorescence. Three mice
per experimental group were employed. Experiments were done in triplicate. ***, p < 0.001, t-test.
3.5. AMPK and Autophagy Increase in the Ovary of DHEA Mice
Given the cooperation of SIRT1 with AMPK in regulating cell survival, we explored whether in
PCOS mouse ovaries AMPK activation was associated with increased autophagy. As shown in Figure 8,
we detected a significant increase of AMPK in DHEA mice. Moreover, we detected an upregulation
of its activated form (phospho-AMPK) and an increased ratio of phospho-AMPK in comparison to
total AMPK in DHEA mice confirming the recruitment of this enzyme. We also observed that DHEA
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ovaries exhibited higher levels of LC3-II and lower levels of P62 compared with control as an evidence
of increased autophagy [36,37].
 
6 
 
Figure 8 Figure 8. Western blot analysis of p-AMP-activated protein kinase (AMPK) (a), AMPK (b),
p-AMPK/AMPK ratio (c), microtubule-associated protein light chain 3 (LC3)-II (e) and p62 (f) and
representative images of immunoreactive bands (d). Data are presented as means± SEM of densitometric
analysis of immunoreactive bands normalized to internal reference protein (glyceraldehyde-3-phosphate
dehydrogenase, GAPDH). Three mice per experimental group were employed. Experiments were done
in triplicate. *, p < 0.05, **, p < 0.01, ***, p < 0.001, t-test.
4. Discussion
Recently, it has emerged that overload of AGEs is a key factor in ovarian dysfunctions and
reduced fertility associated with PCOS. Nevertheless, the specific role of MG, known as the most
powerful AGE precursor involved in the pathogenesis of type 2 diabetes and several other age-related
chronic inflammatory diseases, has been poorly investigated [38,39]. In our previous study we
demonstrated that mice receiving oral MG administration for about one month presented early signs
of the hyperandrogenic status associated with PCOS [17]. Moreover, Lin et al. [40] demonstrated that
dietary supplementation with MG-BSA (bovine serum albumin) generated phenotypes similar to those
observed in the PCOS rat model induced by DHEA. In the present work, we showed for the first time
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that MG-dependent glycative stress participates in the ovarian PCOS phenotype. Moreover, from our
results it appears that this condition is associated with changes of SIRT1 functional network regulating
mitochondrial physiology and cell survival.
Numerous rodent models have been established to study the mechanisms and possible therapies for
PCOS [41]. In our study, we relied on a well-established DHEA-induced PCOS mouse model [20,41,42]
and expanded the characterization of the ovarian microenvironment in DHEA mice. As expected,
we detected anovulation in association with an increased number of atretic antral follicles [43]. In
accordance with Huang et al. [44], DHEA mice employed in this study presented reduced ovulation
rate and oocyte quality, in terms of altered meiotic spindle and chromosome configuration, following
superovulation. This result is consistent with the hypothesis that alterations in oocyte competence
underlie subfertility in many women with PCOS and confirms that hyperandrogenism is a main factor
in this PCOS phenotype [45].
Further, we observed that DHEA ovaries were characterized by altered collagen deposition
revealing the increased fibrotic tissue typically observed in the interstitial area of ovaries from PCOS
patients [46]. We also provided evidence for increased vascularization in DHEA ovaries, which can
be considered an effect of deregulation of ovarian angiogenesis contributing to abnormal follicular
development in PCOS patients [47]. In DHEA mice it can be also observed a significant intraovarian
accumulation of lipid droplets, which is consistent with altered fatty acid composition recently found in
the follicular fluid of PCOS patients [48]. Intraovarian dyslipidemia may account for PCOS associated
changes in follicle metabolism and for reduced oocyte competence in many PCOS patients [48].
Moreover, exposure of cumulus oocyte complexes to high lipid concentration is known to negatively
influence oocyte maturation [49]. Finally, altered steroidogenesis at ovarian level is evidenced by
increased expression of the isoform IV of the androgenic enzyme 17β-HSD in granulosa cells of DHEA
ovaries, a finding that highlights the need for further investigation in PCOS women [50–52].
Different approaches have led us to demonstrate that MG-dependent glycative stress participates
in the ovarian PCOS phenotype. Although MG levels have not been monitored, the finding
of increased MG-AGE deposition represents an evidence of disrupted balance in the process of
detoxification/formation of MG in the ovary of DHEA mice. The potential role of MG in ovarian
dysfunctions has been well established in previous studies from our research group [22–24]. Based
on in vitro studies, exposure to supraphysiological MG concentrations impairs oocyte meiosis and
decreases inner mitochondrial redox potential and distribution [53]. Investigation on the regulation of
glyoxalases has led us to demonstrate that upregulation of GLO1 and GLO2 expression in response
to MG insult is dependent on SIRT1 activity in mouse oocytes. Similarly, oral administration of MG
resulted in the up-expression of ovarian SIRT1 functional network and GLO1, as components of an
adaptive response capable to counteract MG-AGE accumulation [17]. By contrast, here we observed
that DHEA administration was responsible for increased intraovarian MG-AGE levels in association
with enhanced expression of RAGEs and deregulation of the glyoxalase system, represented by reduced
expression of GLO1, a well-known hallmark of glycative stress, and increased GLO2 level. MG
accumulation in DHEA ovaries may derive from both altered glucose metabolism [41] and oxidative
stress [10]. Here, oxidative stress has been evidenced by increased lipid peroxidation in DHEA ovaries
in accordance with data previously reported in DHEA Balb/C mice [54]. MG increases as a result of
reduced GLO1 protein, which is likely to be associated with reduced GLO1 activity, as it occurs in
aged mouse ovaries [22]. Indeed, oxidative damage, by altering GSH availability, may negatively
affect GLO1 activity. Furthermore, glycative stress may account for increased fibrosis and altered
vascularization here observed in DHEA ovaries.
Recently, the interest in the involvement of SIRT1 in PCOS development and progression has
been increasing [19]. Here we found that DHEA mice exhibited enhanced ovarian expression of SIRT1.
Indeed, increased expression of sirtuins is considered an adaptive response to mild oxidative stress,
whereas severe oxidant conditions determined sirtuin degradation [55]. The recruitment of SIRT1 in
DHEA ovarian response to prooxidant conditions is supported by the rise in protein levels of SIRT3
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and SOD2, which are mitochondrial elements of SIRT1 functional network involved in antioxidant
response. Nevertheless, this machinery is not able to prevent mitochondrial failure evidenced by the
decrease of PGC1α, mtTFA and TOMM20. This clearly indicated that a decrease in mitochondria
number occurred in PCOS. Indeed, PGC1α is the major regulator of mitochondrial biogenesis and
function, whereas mtTFA is mitochondrial transcription factor whose levels directly reflect the levels of
mtDNA content, thus being considered a marker of mitochondrial number [25,26]. In strong accordance
with this finding, the reduction in mitochondrial number was further confirmed by semi-quantitative
immunofluorescence-based analysis for TOMM20, a protein in the outer mitochondrial membrane,
which is also considered a marker of mitochondrial mass [56]. Therefore, a decrease of resident
mitochondrial proteins would be expected in case of reduced mitochondrial pool. Conversely, we
found that SOD2 and SIRT3, both located in mitochondria and strictly involved in mitochondrial
antioxidant defense [57,58], were up-regulated in DHEA mice, as compared to control mice. This
counterintuitive trend clearly suggests that PCOS altered the redox milieu within ovarian mitochondria,
as indicated by the marked activation of the SIRT3/SOD2-driven antioxidant response. Our results
support the involvement of mitochondria in this disease and represent the first evidence of mitochondria
deregulation at ovarian level [59]. Further investigation will be required to clarify the relationship
between ovarian mitochondrial changes here described in DHEA mice and energy production.
Based on the recent finding of increased autophagy in PCOS ovarian cells [28,29], we investigated
the presence of this PCOS phenotype in DHEA mice. As recently reviewed by Yoshii and
Mitzushima [37], the increase in LC3-II we found in this study represents an evidence that
DHEA-induced PCOS is characterized by augmented autophagic flux. This was further confirmed by
the data related to p62, which decreases when autophagy is induced [36]. It is important to remark that
SIRT1 regulates autophagy machinery through multiple mechanisms, including direct deacetylation of
autophagy-related proteins such as LC3 [60], or via the activation of AMP-activated kinase (AMPK),
another important energy sensor [27]. In the present study, we found that up-regulation of SIRT1 in
DHEA ovaries is associated with increased AMPK activation and the presence of autophagy markers,
thus indicating that a SIRT1/AMPK axis modulates autophagy in PCOS ovaries.
Overall, present findings represent an important contribution to the characterization of biochemical
markers of DHEA mouse model and to elucidation of new molecular mechanisms underlying PCOS
development or progression at ovarian level. In particular, our results demonstrate the role of MG
in the glycative stress detected in PCOS and highlight the need for further investigation of the
implication of SIRT1, mitochondria and autophagy in the pathogenesis of PCOS. Approaches aimed to
reduce MG burden can potentially form the basis for new treatment strategies for ameliorating PCOS
fertility potential.
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